Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

CD19-Directed CAR T Cell Therapy in 4 Patients with Refractory Multiple Sclerosis

Blood (2024) 144 (Supplement 1): 2073.

https://doi.org/10.1182/blood-2024-205103

Published: 2024

Journal Articles

Impact of High-Risk Disease on Outcome after CAR-T Cell Therapy for Multiple Myeloma: A Meta-Analysis of 759 Patients

Nico Gagelmann, Francis A. Ayuk, Anita Badbaran, Carolina Berger, Boris Fehse, Nicolaus Kroeger

Blood (2022) 140 (Supplement 1): 7241–7242.

https://doi.org/10.1182/blood-2022-170061

Published: 2022

Journal Articles

Targeting Molecular Remission with Donor Lymphocyte Infusions Shows Excellent Outcomes for Persistent or Relapsed Myelofibrosis after Stem Cell Transplantation

Nico Gagelmann, Anita Badbaran, Christine Wolschke, Raissa Adjallé, Dietlinde Janson, Carolina Berger, Evgeny Klyuchnikov, Boris Fehse, Francis A. Ayuk, Nicolaus Kroeger

Blood (2022) 140 (Supplement 1): 7672–7673.

https://doi.org/10.1182/blood-2022-170107

Published: 2022

Journal Articles

Viral Reactivation and Immune Reconstitution after CAR-T Cell Treatment in Patients with Hematologic Malignancies

Ameya Shrinivas Kunte, Nico Gagelmann, Anita Badbaran, Carolina Berger, Radwan Massoud, Evgeny Klyuchnikov, Christine Wolschke, Dietlinde Janson, Ulrike Fritsche-Friedland, Boris Fehse, Nicolaus Kroeger, Francis A. Ayuk

Blood (2022) 140 (Supplement 1): 7531–7532.

https://doi.org/10.1182/blood-2022-168667

Published: 2022

Journal Articles

CAR-HEMATOTOX: a model for CAR T-cell–related hematologic toxicity in relapsed/refractory large B-cell lymphoma

Blood (2021) 138 (24): 2499–2513.

https://doi.org/10.1182/blood.2020010543

Published: 2021

Includes: Supplemental data

Journal Articles

Identification of Predictive Markers of Severe and Prolonged Neutropenia after CD19-Specific CAR T-Cell Treatment in Patients with Relapsed/Refractory B-Cell Malignancies

Kai Rejeski, MD, Carolina Berger, Liv Jentzsch, Semjon Willier, MD, Viktoria Blumenberg, MD, Veit Buecklein, MD, Christoph Faul, MD, Christian Schmidt, MD, Michael von Bergwelt, MD PhD, Tobias Feuchtinger, MD, Wolfgang Bethge, MD, Francis A. Ayuk, Marion Subklewe, MD

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-141833

Published: 2020

Journal Articles

Addition of Fludarabine to Cyclophosphamide Lymphodepletion Improves In Vivo Expansion of CD19 Chimeric Antigen Receptor-Modified T Cells and Clinical Outcome in Adults with B Cell Acute Lymphoblastic Leukemia

Cameron J Turtle, MBBS, PhD, Laila-Aicha Hanafi, PhD, Carolina Berger, MD, Daniel Sommermeyer, PhD, Barbara Pender, MS, Emily M Robinson, BS, Katherine Melville, Tanya M Budiarto, BSc, Natalia N Steevens, Colette Chaney, RN, Sindhu Cherian, MD, Brent L Wood, MD PhD, Lorinda Soma, MD, Xueyan Chen, MD PhD, Shelly Heimfeld, PhD, Michael C Jensen, MD, Stanley R. Riddell, MD, David G Maloney, MD PhD

Blood (2015) 126 (23): 3773.

https://doi.org/10.1182/blood.V126.23.3773.3773

Published: 2015

Journal Articles

Anti-CD19 Chimeric Antigen Receptor-Modified T Cell Therapy for B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Fludarabine and Cyclophosphamide Lymphodepletion Improves In Vivo Expansion and Persistence of CAR-T Cells and Clinical Outcomes

Cameron J Turtle, MBBS, PhD, Carolina Berger, MD, Daniel Sommermeyer, PhD, Laila-Aicha Hanafi, PhD, Barbara Pender, MS, Emily M Robinson, BS, Katherine Melville, Tanya M Budiarto, BSc, Natalia N Steevens, Colette Chaney, RN, Sindhu Cherian, MD, Brent L Wood, MD PhD, Lorinda Soma, MD, Xueyan Chen, MD PhD, Shelly Heimfeld, PhD, Michael C Jensen, MD, Stanley R. Riddell, MD, David G Maloney, MD PhD

Blood (2015) 126 (23): 184.

https://doi.org/10.1182/blood.V126.23.184.184

Published: 2015

Journal Articles

Therapy of B Cell Malignancies with CD19-Specific Chimeric Antigen Receptor-Modified T Cells of Defined Subset Composition

Cameron J Turtle, MBBS, PhD, Daniel Sommermeyer, PhD, Carolina Berger, MD, Michael Hudecek, MD, David M Shank, Natalia N Steevens, BS, Tanya M Budiarto, BSc, Mandana Karimi, MS, Colette N Chaney, RN, Anna Marie DeVito, RN, Shelly Heimfeld, PhD, Michael C Jensen, MD, Stanley R Riddell, MD, David G Maloney, MDPhD

Blood (2014) 124 (21): 384.

https://doi.org/10.1182/blood.V124.21.384.384

Published: 2014

Journal Articles

Truncated Cell-Surface CD19 As a Conditional Suicide Switch For Adoptive T Cell Immunotherapy

Lihua Elizabeth Budde, MD, PhD, Armen Mardiros, MS, Wen-Chung Chang, MS, Xiuli Wang, MD, PhD, Carolina Berger, MD, Christine Brown, PhD, Stanley R Riddell, MD, Oliver W. Press, MD, PhD, Stephen J. Forman, MD

Blood (2013) 122 (21): 1660.

https://doi.org/10.1182/blood.V122.21.1660.1660

Published: 2013

Journal Articles

Engraftment of human central memory-derived effector CD8 + T cells in immunodeficient mice

Xiuli Wang, Carolina Berger, ChingLam W. Wong, Stephen J. Forman, Stanley R. Riddell, Michael C. Jensen

Blood (2011) 117 (6): 1888–1898.

https://doi.org/10.1182/blood-2010-10-310599

Published: 2011

Includes: Supplemental data

Journal Articles

Safety and immunologic effects of IL-15 administration in nonhuman primates

Carolina Berger, Michael Berger, Robert C. Hackman, Michael Gough, Carole Elliott, Michael C. Jensen, Stanley R. Riddell

Blood (2009) 114 (12): 2417–2426.

https://doi.org/10.1182/blood-2008-12-189266

Published: 2009

Includes: Supplemental data

Journal Articles

In Vivo Administration of Interleukin 15 (IL-15) Safely Promotes the Survival and Proliferation of Adoptively Transferred Antigen-Specific T Cell Clones

Carolina Berger, MD, Michael Berger, Michael C Jensen, MD, Stanley R Riddell, MD

Blood (2008) 112 (11): 679.

https://doi.org/10.1182/blood.V112.11.679.679

Published: 2008

Journal Articles

Use of Gene-Modified T-Cells as Antigen Presenting Cells (T-APC) for Vaccination Against Myeloma Antigens.

Larry D. Anderson, Jr, MD, PhD, Danielle R. Cook, Carolina Berger, MD, David G. Maloney, MD, PhD, Stanley R. Riddell, MD

Blood (2007) 110 (11): 2758.

https://doi.org/10.1182/blood.V110.11.2758.2758

Published: 2007

Journal Articles

Establishing T Cell Memory by Adoptive Transfer of T Cell Clones.

Carolina Berger, MD, Michael C. Jensen, MD, Stanley R. Riddell, MD

Blood (2006) 108 (11): 866.

https://doi.org/10.1182/blood.V108.11.866.866

Published: 2006

Journal Articles

Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK–modified donor T cells after allogeneic hematopoietic cell transplantation

Carolina Berger, Mary E. Flowers, Edus H. Warren, Stanley R. Riddell

Blood (2006) 107 (6): 2294–2302.

https://doi.org/10.1182/blood-2005-08-3503

Published: 2006

Journal Articles

Development of a Nonhuman Primate Model for Analysis of the Adoptive Transfer of Antigen-Specific T Cell Clones.

Carolina Berger, MD, Michael Jensen, MD, Stanley R. Riddell, MD

Blood (2005) 106 (11): 770.

https://doi.org/10.1182/blood.V106.11.770.770

Published: 2005

Journal Articles

Pharmacologically regulated Fas-mediated death of adoptively transferred T cells in a nonhuman primate model

Carolina Berger, C. Anthony Blau, Meei-Li Huang, John D. Iuliucci, David C. Dalgarno, Joëlle Gaschet, Shelly Heimfeld, Tim Clackson, Stanley R. Riddell

Blood (2004) 103 (4): 1261–1269.

https://doi.org/10.1182/blood-2003-08-2908

Published: 2004

Journal Articles

CD28 costimulation and immunoaffinity-based selection efficiently generate primary gene-modified T cells for adoptive immunotherapy

Carolina Berger, C. Anthony Blau, Tim Clackson, Stanley R. Riddell, Shelly Heimfeld

Blood (2003) 101 (2): 476–484.

https://doi.org/10.1182/blood-2002-07-2142

Published: 2003

NARROW

CD19-Directed CAR T Cell Therapy in 4 Patients with Refractory Multiple Sclerosis

Impact of High-Risk Disease on Outcome after CAR-T Cell Therapy for Multiple Myeloma: A Meta-Analysis of 759 Patients

Targeting Molecular Remission with Donor Lymphocyte Infusions Shows Excellent Outcomes for Persistent or Relapsed Myelofibrosis after Stem Cell Transplantation

Viral Reactivation and Immune Reconstitution after CAR-T Cell Treatment in Patients with Hematologic Malignancies

CAR-HEMATOTOX: a model for CAR T-cell–related hematologic toxicity in relapsed/refractory large B-cell lymphoma

Identification of Predictive Markers of Severe and Prolonged Neutropenia after CD19-Specific CAR T-Cell Treatment in Patients with Relapsed/Refractory B-Cell Malignancies

Addition of Fludarabine to Cyclophosphamide Lymphodepletion Improves In Vivo Expansion of CD19 Chimeric Antigen Receptor-Modified T Cells and Clinical Outcome in Adults with B Cell Acute Lymphoblastic Leukemia

Anti-CD19 Chimeric Antigen Receptor-Modified T Cell Therapy for B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Fludarabine and Cyclophosphamide Lymphodepletion Improves In Vivo Expansion and Persistence of CAR-T Cells and Clinical Outcomes

Therapy of B Cell Malignancies with CD19-Specific Chimeric Antigen Receptor-Modified T Cells of Defined Subset Composition

Truncated Cell-Surface CD19 As a Conditional Suicide Switch For Adoptive T Cell Immunotherapy

Engraftment of human central memory-derived effector CD8 + T cells in immunodeficient mice

Safety and immunologic effects of IL-15 administration in nonhuman primates

In Vivo Administration of Interleukin 15 (IL-15) Safely Promotes the Survival and Proliferation of Adoptively Transferred Antigen-Specific T Cell Clones

Use of Gene-Modified T-Cells as Antigen Presenting Cells (T-APC) for Vaccination Against Myeloma Antigens.

Establishing T Cell Memory by Adoptive Transfer of T Cell Clones.

Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK–modified donor T cells after allogeneic hematopoietic cell transplantation

Development of a Nonhuman Primate Model for Analysis of the Adoptive Transfer of Antigen-Specific T Cell Clones.

Pharmacologically regulated Fas-mediated death of adoptively transferred T cells in a nonhuman primate model

CD28 costimulation and immunoaffinity-based selection efficiently generate primary gene-modified T cells for adoptive immunotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only